These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8491984)
1. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984 [TBL] [Abstract][Full Text] [Related]
2. Acitretin is converted to etretinate only during concomitant alcohol intake. Grønhøj Larsen F; Steinkjer B; Jakobsen P; Hjorter A; Brockhoff PB; Nielsen-Kudsk F Br J Dermatol; 2000 Dec; 143(6):1164-9. PubMed ID: 11122016 [TBL] [Abstract][Full Text] [Related]
3. Acitretin : A Review of its Pharmacology and Therapeutic Use. Pilkington T; Brogden RN Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients. Larsen FG; Jakobsen P; Eriksen H; Grønhøj J; Kragballe K; Nielsen-Kudsk F J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis. Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077 [TBL] [Abstract][Full Text] [Related]
7. [Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy]. Almond-Roesler B; Orfanos CE Hautarzt; 1996 Mar; 47(3):173-7. PubMed ID: 8647698 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients. Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472 [TBL] [Abstract][Full Text] [Related]
9. Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment. Meyer E; de Bersaques J; Lambert WE; de Leenheer AP; Kint AH Acta Derm Venereol; 1993 Apr; 73(2):113-5. PubMed ID: 8103254 [TBL] [Abstract][Full Text] [Related]
10. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients. Bjerke JR; Geiger JM Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847 [TBL] [Abstract][Full Text] [Related]
11. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis. Lauharanta J; Paravicini U Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628 [No Abstract] [Full Text] [Related]
12. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use]. Gollnick H; Rinck G; Bitterling T; Orfanos CE Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274 [TBL] [Abstract][Full Text] [Related]
13. Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment. Sturkenboom MC; de Jong-Van Den Berg LT; van Voorst-Vader PC; Cornel MC; Stricker BH; Wesseling H Br J Clin Pharmacol; 1994 Sep; 38(3):229-35. PubMed ID: 7826824 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography. Decker MA; Zimmerman CL J Chromatogr B Biomed Appl; 1995 May; 667(1):105-13. PubMed ID: 7663673 [TBL] [Abstract][Full Text] [Related]
15. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy. Löfberg B; Reiners J; Spielmann H; Nau H Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001 [TBL] [Abstract][Full Text] [Related]
16. A potentially new metabolic pathway: ethyl esterification of acitretin. Chou RC; Wyss R; Huselton CA; Wiegand UW Xenobiotica; 1992 Aug; 22(8):993-1002. PubMed ID: 1413887 [TBL] [Abstract][Full Text] [Related]
17. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606 [TBL] [Abstract][Full Text] [Related]
19. The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs. Vena GA; Cassano N Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):959-72. PubMed ID: 22594656 [TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate. Knights KM; Gasser R; Klemisch W Biochem Pharmacol; 2000 Aug; 60(4):507-16. PubMed ID: 10874125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]